In addition, the addition of sGC inhibitor NS-2028 and PKG inhibitor KT5823 significantly blocked the increase of cGMP levels (Fig. 5H, I) and pVASP levels (Fig. 5J, K) in gastric cancer cells induced by PRTG overexpression. The gene discussed is PRKG1; the disease is gastric cancer.